New diabetes clinical trial: Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for Open Wounds
Published on: June 26, 2025 at 11:00PM Conditions : Diabetic Foot Ulcer; Chronic Wounds; Cellular, Acellular, Matrix-like Product (CAMP); Cellular and/or Tissue Product (CTP); Dehydrated Complete Human Placental Membrane (dCHPM) Interventions : Other: NeoThelium FT Sponsors : NuScience Medical Biologics, LLC; SygNola, LLC Not yet recruiting https://ift.tt/h9gtM0S